Relative contributions of codon usage, promoter efficiency and leader sequence to the antigen expression and immunogenicity of HIV-1 Env DNA vaccine
- 22 May 2006
- journal article
- Published by Elsevier BV in Vaccine
- Vol. 24 (21), 4531-4540
- https://doi.org/10.1016/j.vaccine.2005.08.023
Abstract
No abstract availableThis publication has 24 references indexed in Scilit:
- Independent but not synergistic enhancement to the immunogenicity of DNA vaccine expressing HIV-1 gp120 glycoprotein by codon optimization and C3d fusion in a mouse modelVaccine, 2004
- Multiple Effects of Codon Usage Optimization on Expression and Immunogenicity of DNA Candidate Vaccines Encoding the Human Immunodeficiency Virus Type 1 Gag ProteinJournal of Virology, 2001
- Short Communication: Immunogenicity of DNA Vaccines Expressing Human Immunodeficiency Virus Type 1 Envelope Glycoprotein with and without Deletions in the V1/2 and V3 RegionsAIDS Research and Human Retroviruses, 1998
- Signal peptide fragments of preprolactin and HIV-1 p-gp160 interact with calmodulinThe EMBO Journal, 1997
- Codon usage limitation in the expression of HIV-1 envelope glycoproteinCurrent Biology, 1996
- Identification of a novel component of the nonsense-mediated mRNA decay pathway by use of an interacting protein screen.Published by Cold Spring Harbor Laboratory ,1995
- Control of Expression, Glycosylation, and Secretion of HIV-1 gp120 by Homologous and Heterologous Signal SequencesVirology, 1994
- mRNA destabilization triggered by premature translational termination depends on at least three cis-acting sequence elements and one trans-acting factor.Genes & Development, 1993
- Higher Level Organization of Individual Gene Transcription and RNA SplicingScience, 1993
- Unusual codon usage of HIVNature, 1987